Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousStem CellsHematopoietic Stem CellsTransplantation ConditioningHematopoietic Stem Cell MobilizationMelphalanGraft vs Host DiseaseMultiple MyelomaHematologic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeBone Marrow TransplantationLeukapheresisAntigens, CD34Granulocyte Colony-Stimulating FactorCyclophosphamideRemission InductionSalvage TherapyEtoposideMyeloablative AgonistsBlood Component RemovalLymphoma, Non-HodgkinRecurrenceGraft SurvivalDisease-Free SurvivalTissue DonorsHodgkin DiseaseBusulfanThiotepaCytarabineSurvival RateRetrospective StudiesHistocompatibility TestingBone Marrow PurgingTransplantation ChimeraWhole-Body IrradiationHematopoiesisCarmustineStem Cell NicheSurvival AnalysisAdult Stem CellsVincristineCord Blood Stem Cell TransplantationEmbryonic Stem CellsAntineoplastic Agents, AlkylatingCell DifferentiationImmunosuppressive AgentsTransplantationAmyloidosisFollow-Up StudiesLeukemiaTime FactorsDoxorubicinIfosfamideMesenchymal Stem Cell TransplantationDexamethasonePrognosisImmunocompromised HostBone MarrowHistocompatibilityBone Marrow CellsHepatic Veno-Occlusive DiseaseLymphomaFlow CytometryPluripotent Stem CellsAntineoplastic AgentsLeukemia, Myeloid, AcuteAntibodies, Monoclonal, Murine-DerivedAnemia, AplasticLymphoma, Mantle-CellCell LineageBoronic AcidsCells, CulturedPyrazinesNeoplasm, ResidualBlood CellsLymphoma, FollicularPodophyllotoxinCytomegalovirus InfectionsColony-Forming Units AssayHLA AntigensPrednisoneNeural Stem CellsMyelodysplastic SyndromesThalidomideBlood Cell CountVidarabineLymphoma, T-Cell, PeripheralFetal BloodProspective StudiesInduced Pluripotent Stem CellsNeoplasmsKidney TransplantationMesenchymal Stromal CellsMice, Inbred C57BL